Ontario limits funding for glucose test stripsMinistry suggests pharmacists use patient questions about change as opportunity to provide MedsCheck for diabetes. ARBs vary in efficacy for preventing cardiovascular events in diabetes patientsNew CMAJ study suggests that telmisartan or valsartan may be the preferred angiotensin receptor blockers for preventing cardiovascular events in patients with diabetes. Diabetes videos provide valuable teaching aid for pharmacists Resources are practical tools for pharmacists to use when teaching patients. Clinical Notes: Assessment and management of diabetic foot ulcers Clarification: diabetes guidelines Rosiglitazone revival? FDA committee ruling seems unlikely to win drug new fans MI prevention: We could be doing better Screening for risk factors is not optimal Diabetes link strengthened Help assess my patient's diabetes therapy A patient came to me with two concerns. First, how long should she wait before retaking Janumet and GlucoNorm? Second, is there compatible insulin that she can take in place of her oral diabetic medications? The 2013 diabetes guidelines: New tools, new targets A1c now accepted for diagnosis; treatment goals gain flexibility First Previous 42 43 44 45 46 Next Last
